Traditional Wound Management Market to Record an Exponential CAGR by 2028

 

Traditional Wound Management Market Growth & Trends

The global traditional wound management market size is expected to reach USD 7.7 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 3.7% from 2021 to 2028. The rising incidence of chronic diseases, increasing number of accidents, and rising number of ambulatory surgery centers (ASCs) are the key driving factors for the market.

The global increase in the incidence of chronic diseases such as diabetes, cancer, and other autoimmune diseases is one of the key driving factors for market growth. Factors such as the adoption of unhealthy and sedentary lifestyles, alcohol consumption, and smoking are majorly contributing to the rise in the prevalence of non-communicable diseases. Cancer has been a global healthcare burden as it is one of the leading causes of death. Most surgical wounds post-cancer surgery are relatively large in size and deep, producing exudate that requires regular care.

The wound care products such as bandages, medical tapes, and gauze help to manage large wounds, significantly reducing the risk of further infection. According to the estimates from the WHO, in 2018, one in five men and one in six women globally develop cancer during their lifetime. Moreover, as per reports published by WHO, 18.1 million new cancer cases have been reported in 2018, globally. In addition, it also reported that over 70.0% of cancer-related deaths typically occur in middle- and low-income countries. Furthermore, the rising prevalence of chronic conditions and the number of surgeries being performed have also increased globally. Therefore, such factors are anticipated to positively impact market growth over the forecast period.

Request a free sample copy or view report summary: Traditional Wound Management Market Report

Traditional Wound Management Market Report Highlights

• In terms of revenue, the acute wounds segment held the largest revenue share in 2020 owing to the rising cases of accidents and trauma globally
• The gauze segment held the largest share in 2020 owing to its wide range of applicability in various types of injuries and availability of numerous products
• The hospital segment dominated the market and held the largest revenue share in 2020 due to the rising cases of burns and surgeries
• In Asia Pacific, the market is expected to witness the fastest growth rate over the forecast period owing to the rising number of diabetic patients in this region

Access Press Release@ https://www.grandviewresearch.com/press-release/global-traditional-wound-management-market

Traditional Wound Management Market Segmentation

Grand View Research has segmented the global traditional wound management market on the basis of product, application, end-use, and region:

Traditional Wound Management Product Outlook (Revenue, USD Million, 2016 - 2028)

• Gauze
• Tape
• Bandage
• Cotton

Traditional Wound Management Application Outlook (Revenue, USD Million, 2016 - 2028)

• Chronic Wounds
  • Diabetic Foot Ulcers
  • Pressure Ulcers
  • Venous Leg Ulcers
  • Other Chronic Wounds
• Acute Wounds
  • Surgical & Traumatic Wounds
  • Burns

Traditional Wound Management End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospitals
• Clinics
• Home Healthcare
• Others

Traditional Wound Management Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
• Asia Pacific
  • Japan
  • China
• Latin America
  • Brazil
  • Mexico
• MEA
  • South Africa
  • Saudi Arabia

 List of Key Players of Traditional Wound Management Market

• Braun Melsungen AG
• Johnson & Johnson Pvt. Ltd.
• Medtronic PLC
• Smith & Nephew
• PAUL HARTMANN AG
• Cardinal Health
• Mölnlycke Health Care AB
• Derma Sciences Inc.
• Medline Industries, Inc.
• BSN Medical

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Wheelchair Market to Witness a Pronounce Growth During 2021 – 2028: Grand View Research Inc.

 Wheelchair Market Growth & Trends

The global wheelchair market size is expected to reach USD 4.9 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.0% from 2021 to 2028. The Americans with Disabilities Act (ADA) defines a wheelchair as a manually operated or automated device, designed primarily for use by an individual with a mobility disability. It is mainly used for the purpose of indoor or both indoor and outdoor locomotion. Increase in life span and numbers of elderly persons at a global level is one of the key reasons expected to contribute towards the growth of the market.

The growing integration of automation in healthcare devices, especially mobility devices, such as wheelchairs is a key impacting parameter, projected to support market growth. Wheelchairs today are incorporated with non-linear processing circuits, guide sensors, pulse steering drive, and several controls for making the ride easy and smooth for patients.

Rise in number of disorders requiring a mobility device is also one of the key factors expected to contribute to market growth. One of the common disabilities that require a mobility device is the spinal cord injuries. According to the National Spinal Cord Injury Statistical Center’s Facts and Figures at a Glance 2020, there are around 294,000 people currently living with spinal cord injuries (SCI), in the U.S. with 17,810 new cases each year. Thus, the US is expected to be a key potential market for the manufacturers of the mobility device in the years to come.

The recent COVID-19 pandemic affected the manufacturing and supply chain aspect of the manufacturers to a great extent. Wheelchair services were halted across several countries owing to strict lockdowns being implemented. This had left many wheelchair users in a fix. The manufacturers also faced difficulty since their operations were halted. Although the number of hospital visits by regular patients had reduced during the lockdown, the number of patients affected with COVID-19 witnessed a spike. Thus, demand for the mobility device increased during this period, especially from the hospital segment. With the ease of lockdowns, the manufacturing operation of the mobility device is expected to come back to normal.

Request a free sample copy or view report summary: Wheelchair Market Report

Wheelchair Market Report Highlights

• The manual product segment led the segment in terms of revenue share in 2020 owing to its increasing use in hospitals. It is also cost-effective and requires little maintenance
• Rising volume of medical emergencies is a prime factor driving the hospital segment
• The adults segment was the largest in 2020 in terms of revenue share owing to rise in number of disabilities requiring a mobility device such as the spinal cord injuries and an expanding ageing population
• North America dominated the market with a revenue share of 35.0% due to increased adoption of advanced technology in wheelchairs and rise in the disabled population

Access Press Release@ https://www.grandviewresearch.com/press-release/global-wheelchair-market

Wheelchair Market Segmentation

Grand View Research has segmented the global wheelchair market based on product, category, application, and region:

Wheelchair Product Outlook (Revenue, USD Million, 2016 - 2028)

• Manual
• Electric

Wheelchair Category Outlook (Revenue, USD Million, 2016 - 2028)

• Adults
• Pediatric

Wheelchair Application Outlook (Revenue, USD Million, 2016 - 2028)

• Homecare
• Hospitals
• Ambulatory Surgical Centers
• Rehabilitation Centers

Wheelchair Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Columbia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Wheelchair Market

• Carex Health Brands, Inc.
• Drive Medical Design & Manufacturing
• Graham-Field Health Products Inc.
• Invacare
• Medline
• Sunrise Medical LLC
• Karman Healthcare
• Quantum Rehab
• Numotion
• Pride Mobility Products Corp.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Fitness App Market to Surpass USD 15.5 Billion by 2028: Grand View Research Inc.

 Fitness App Market Growth & Trends

The global fitness app market size is expected to reach USD 15.5 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 21.6% from 2021 to 2028. Rising health and fitness awareness and the growing prevalence of obesity are major factors driving the global market. According to the Centers for Disease Control and Prevention, the prevalence of obesity increased from 30.5% in 1999-2000 to 42.4% in 2017-2018. Moreover, awareness regarding obesity-related health conditions, including diabetes, stroke, heart diseases, and cancer, is increasing. This, in turn, is fueling the adoption of fitness apps to manage weight and aid weight loss.

The lockdown and social distancing norms by governments to control the spread of the COVID-19 virus have negatively impacted the gyms and fitness centers globally. However, consumers have shifted their focus to online fitness classes and apps. The total number of downloads and active users increased rapidly during the COVID-19 lockdown. For instance, the daily active users on fitness apps increased by 24% in Asia Pacific, 11% in Europe, 8% in Americas, and 28% in the Middle East and North Africa between quarter 1 and quarter 2 of 2020. Moreover, many fitness apps are witnessing an increase in their downloads and profits. For instance, HealthifyMe, an Indian fitness app, witnessed a 30% increase in traffic and a 40% increase in revenue in April 2020.

Moreover, a rise in the number of product launches, investments, collaborations, partnerships, and mergers & acquisitions is boosting the adoption of fitness apps in the market. For instance, in March 2020, Curefit, a health and fitness company, received USD 110 million in funding from Temasek Holdings Limited. In November 2020, Hong Kong Baptist University (HKBU) and The Chinese University of Hong Kong (CUHK) collaborated to launch MusFit Action Mobile App, which is focused on home-based exercises for elderly and middle-aged people. In December 2020, National Football League player DeMarcus Ware introduced his fitness app Driven to Win on Apple Store. The subscribers can work out with NBL players through this app. This app will be available for Android from 2021.

Request a free sample copy or view report summary: Fitness App Market Report

Fitness App Market Report Highlights

• The exercise and weight loss segment emerged as the leading type segment in 2020 with a revenue share of 54.7%
• By platform, iOS accounted for the largest revenue share in 2020. The Android segment is projected to expand at the fastest CAGR during the forecast period
• Based on the device, smartphones accounted for the largest revenue share in 2020. Wearable devices are projected to expand at the fastest CAGR during the forecast period
• North America accounted for the largest share in 2020 due to the increasing awareness regarding health and wellness, high penetration of smartphones, and availability of a large number of fitness apps

Access Press Release@ https://www.grandviewresearch.com/press-release/global-fitness-app-market

Fitness App Market Segmentation

Grand View Research has segmented the global fitness app market on the basis of type, platform, device, and region:

Fitness App Type Outlook (Revenue, USD Million, 2016 - 2028)

• Exercise & Weight Loss
• Diet & Nutrition
• Activity Tracking

Fitness App Platform Outlook (Revenue, USD Million, 2016 - 2028)

• Android
• iOS
• Others

Fitness App Device Outlook (Revenue, USD Million, 2016 - 2028)

• Smartphones
• Tablets
• Wearable Devices

Fitness App Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • S.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
• Latin America
  • Mexico
  • Brazil
• Middle East & Africa
  • South Africa

List of Key Players of Fitness App Market

• Adidas
• Fitbit, Inc.
• Appster
• Azumio, Inc.
• MyFitnessPal Inc.
• Applico
• FitnessKeeper
• Aaptiv
• Nike
• Noom
• Under Armour, Inc.
• Appinventiv

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Laser Hair Removal Market Industry Analysis Comparing Industry Prospects And Challenges Of Investing

 Laser Hair Removal Market Growth & Trends

The global laser hair removal market size is expected to reach USD 2.8 billion by 2028 registering a CAGR of 20.6% over the forecast period, according to a new report by Grand View Research, Inc. Increasing demand for non-invasive hair removal procedures is expected to drive the market growth. Technological advancements, such as the introduction of ultra-technology, are also projected to boost the market growth.

The ultra-technology is more secure than earlier techniques and the prevalence of side-effects, such as burning sensations and temporary rashes on the skin, can be easily healed with topical applications. Asia Pacific is anticipated to register the fastest CAGR during the forecast period owing to the high prevalence of skin disorders in the emerging economies and the rise in disposable income of consumers. Moreover, growing e-commerce penetration is driving the market due to easy availability of advanced products.

The Covid-19 pandemic has created several challenges for the aesthetics industry. Initially, most of the clinics had halted their services with only emergency procedures to be performed. This has impacted the market growth. However, recently, due to ease of lockdown restrictions, services have resumed in a staggered manner with strict measures to be followed. This will boost the market growth.

Request a free sample copy or view report summary: Laser Hair Removal Market Report

Laser Hair Removal Market Report Highlights

• The Nd:YAG laser type segment is expected to register the fastest CAGR from 2021 to 2028 owing to the high efficiency of these products on all skin types, including tanned skin, and faster repetition rates
• The beauty clinics end-use segment is expected to lead the global market, in terms of revenue share as well as growth rate, during the forecast period owing to an increase in demand for advanced aesthetics devices for hair removal
• The dermatology clinics segment is projected to account for a significant market share by 2028 due to the availability of skilled professionals and efficient treatments with extreme safety and comfort
• North America was the dominant regional market in 2020 and is expected to expand further at a steady CAGR from 2021 to 2028 owing to a huge market of dermatology clinics and the adoption of innovative devices

Access Press Release@ https://www.grandviewresearch.com/press-release/global-laser-hair-removal-market

Laser Hair Removal Market Segmentation

Grand View Research has segmented the global laser hair removal market on the basis of laser type, end-use, and region:

Laser Hair Removal Laser Type Outlook (Revenue, USD Million, 2016 - 2028)

• Diode
• Nd:YAG
• Alexandrite

Laser Hair Removal End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Beauty Clinics
• Dermatology Clinics
• Home Use

Laser Hair Removal Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • Japan
  • India
  • Singapore
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Laser Hair Removal Market

• Syneron Medical Ltd.
• Sciton, Inc.
• Alma Lasers, Ltd.
• Cynosure, Inc.
• Cutera Inc.
• Lumenis Ltd.
• Lutronic Corp.
• Lynton Lasers Ltd.
• Solta Medical, Inc.
• Strata Skin Sciences, Inc.
• Venus Concept Canada Corp.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Demand for Veterinary Artificial Insemination Market to Incur Considerable Upsurge During 2021– 2028: Grand View Research Inc.

 

Veterinary Artificial Insemination Market Growth & Trends

The global veterinary artificial insemination market size is expected to reach USD 6.24 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 5.94% from 2021 to 2028. The market for veterinary artificial insemination is anticipated to witness a rise in demand owing to increasing consumption of animal protein and growing demand for high cattle productivity and milk yield. To fulfill the continuously increasing demand, market players are adopting artificial insemination to breed high-quality livestock and enhance production. For example, in August 2020, Cogent with AB Europe has launched a novel sexed semen service for sheep producers in the U.K. The demand has increased over the years owing to the rising prevalence of various animal diseases, such as zoonotic diseases, and the growing adoption of companion animals.

According to the Food and Agriculture Organization (FAO) publication 2019, livestock contributed almost 40% of the global value of agricultural output in developed countries and 20% in the developing ones, and it provides food security and livelihood to more than 1.3 billion people worldwide. Favorable government regulations intended to improve productivity are also leading to growth. For instance, the Indian government approved an Agriculture Export Policy in 2018 to enhance agricultural economic growth in the nation. The new policy is aimed at boosting India's agricultural output to USD 60 billion by 2022 and USD 100 billion with a predictable foreign policy framework in the next few years.

The market follows the standards set by the International Society of Artificial Insemination (ISAG) and leading animal research laboratories, such as The University of California Davis (U.C. Davis). The ISAG standard panel consists of 18 STR markers and any company in artificial insemination needs to follow the panel and standard set by the authority. However, the increasing population is expected to pose a continuous challenge to food availability and animal protein requirement, aiding the growth of the market.

Request a free sample copy or view report summary: Veterinary Artificial Insemination Market Report

Veterinary Artificial Insemination Market Report Highlights

• On the basis of animal type, the cattle segment was the largest revenue-generating segment in 2020 owing to the increasing consumption of milk and its products in Asian countries
• Based on product, the normal semen segment accounted for the largest revenue share in 2020 owing to the low cost of the procedure
• The sexed semen product segment is expected to witness the fastest growth during the forecast period. In 2016, ST Genetics produced 4 million X chromosome into an AI straw. The company sells sexed semen for five species of animals, including cattle, deer, sheep, horses, and goats. The rate of semen straws ranges between USD 65 and USD 250 for apiece as of 2018, depending on the quality, species, and use of the animal
• By end use, the animal husbandry segment accounted for the largest share in 2020 and is expected to maintain its lead throughout the forecast period. The growth can be attributed to a maximum number of semen collection procedures performed under these facilities
• The Asia Pacific accounted for the largest revenue share in 2020 mainly due to the large cattle population in the region

Access Press Release@ https://www.grandviewresearch.com/press-release/global-veterinary-artificial-insemination-market

Veterinary Artificial Insemination Market Segmentation

Grand View Research has segmented the global veterinary artificial insemination market on the basis of animal type, product, end use, and region:

Veterinary Artificial Insemination Animal Type Outlook (Revenue, USD Million, 2016 - 2028)

• Cattle
• Swine
• Sheep
• Canine
• Equine
• Others

Veterinary Artificial Insemination Product Outlook (Revenue, USD Million, 2016 - 2028)

• Normal Semen
• Sexed Semen

Veterinary Artificial Insemination End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Veterinary Hospitals
• Animal Husbandry
• Others

Veterinary Artificial Insemination Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Veterinary Artificial Insemination Market

• Swine Genetics International
• Select Sires, Inc.
• SEMEX
• Cooperative Resource International (GENEX)
• Zoetis
• Cogent
• Genus plc
• Viking Genetics
• Polar Genetics India Private Limited
• Fox Fire Farm
• Xcell Breeding & Livestock Services Private Limited

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Medical Foods Market To Hold a High Potential for Growth by 2028

 Medical Foods Market Growth & Trends

The global medical foods market size is anticipated to reach USD 30.34 billion by 2028 according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 5.2% over the forecast period. Factors such as the growing prevalence of chronic conditions along with the increasing geriatric population adopting medical foods are positively impacting the growth. Rising awareness regarding clinical nutrition among healthcare professionals and patients is projected to further bolster the growth over the forecast period.

Based on the route of administration, oral administration dominated the market in 2020. Factors contributing to the high share include high commercial viability of orally administered products and high preference for orally administered medical foods owing to ease in consumption. Oral supplements are available in various forms such as powders, pills, puddings, and pre-thickened products, thereby propelling the overall growth.

In 2020, based on product type, the others segment accounted for the highest revenue share. The others' segment comprises of liquid, semi-liquid, and semi-solid products. This growth is attributed to increasing application areas of medical foods, high commercial availability, and easy administration of these products. Owing to ease of consumption, liquid formulations are preferred by geriatric as well as pediatric populations, thereby increasing its overall revenue share.

Based on application, diabetic neuropathy dominated the market share in 2020. Rising diabetes prevalence and an increase in the number of patients that are at risk of developing some level of neuropathy are some of the factors boosting the overall growth. For instance, according to Healthline, around 60% to 70% of people suffering from diabetes have some or other form of neuropathy. The risk of suffering from neuropathy increases with an aging, unhealthy lifestyle, and change in diet which leads to an increased focus on nutritional management, thereby fueling the growth.

In 2020, based on sales channels, institutional sales accounted for the highest revenue share. This share is attributable to higher adoption and consumption of enteral and oral medical foods in healthcare institutions such as hospitals, clinics, and care centers. There is an increase in demand for such products in inpatient facilities. Hence, rising demand and consumption of these products under medical supervision are some of the factors contributing to the growth of the segment.

North America dominated the market with a revenue share of 29.9% in 2020 owing to the presence of key market players and high revenue generated by these players in this region. Strategic initiatives by players, increasing prevalence of chronic conditions, and rising adoption of medical foods by healthcare professionals and patients are other factors supporting the regional market growth.

Request a free sample copy or view report summary: Medical Foods Market Report

Medical Foods Market Report Highlights

• The oral segment accounted for the highest revenue share in 2020, owing to the high commercial viability of orally administered products and high preference for orally administered medical foods
• The others' segment dominated the market in 2020, owing to increasing application areas, high commercial availability, and easy administration of the products
• Diabetic Neuropathy dominated the market in 2020, owing to increasing diabetes prevalence and the rising number of patients that are at risk of developing some level of neuropathy
• Institutional sales accounted for the highest revenue share in 2020, owing to higher adoption and consumption of enteral and oral medical foods in healthcare institutions such as hospitals, clinics, and care centers
• North America dominated the market with a revenue share of 29.9% in 2020, owing to the presence of key market players and high revenue generated by these players in this region

Access Press Release of Medical Foods Market @ https://www.grandviewresearch.com/press-release/global-medical-foods-market

Medical Foods Market Segmentation

Grand View Research has segmented the global medical foods market based on the route of administration, product, application, sales channel, and region:

Medical Foods Route of Administration Outlook (Revenue, USD Million, 2014 - 2028)

• Oral
• Enteral

Medical Foods Product Outlook (Revenue, USD Million, 2014 - 2028)

• Pills
• Powder
• Others

Medical Foods Application Outlook (Revenue, USD Million, 2014 - 2028)

• Chronic Kidney Disease
• Minimal Hepatic Encephalopathy
• Chemotherapy-induced Diarrhea
• Pathogen Related Infections
• Diabetic Neuropathy
• ADHD
• Depression
• Alzheimer's Disease
• Nutritional Deficiency
• Orphan Diseases
  • Phenylketonuria
  • Eosinophilic Esophagitis
  • FPIES
  • Others
• Other 

Medical Foods Sales Channel Outlook (Revenue, USD Million, 2014 - 2028)

• Online Sales
• Retail Sales
• Institutional Sales

Medical Foods Regional Outlook (Revenue, USD Million, 2014 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
• Asia-Pacific
  • Australia
  • China
  • Japan
  • South Korea
  • India
  • New Zealand
  • Singapore
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Medical Foods Market

• Danone
• Nestle Nutrition
• Abbott Nutrition
• Targeted Medical Pharma, Inc.
• Primus Pharmaceuticals, Inc.
• Mead Johnson & Company, LLC.
• Medtrition, Inc.
• Fresenius Kabi AG

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Impact of Existing and Emerging Platelet Rich Plasma Market Trends And Forecast 2021-2028

 Platelet Rich Plasma Market Growth & Trends

The global platelet rich plasma market size is estimated to reach USD 1.2 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 12.0% from 2021 to 2028. Several research studies have been performed recently to assess the conditions and incidences of platelet rich plasma (PRP) usage across both nonoperative as well as operative settings. Recent research on these lines has concluded that the breadth and use of platelet rich plasma have increased significantly among Medicare beneficiaries, which is expected to drive the market.

Technological advancements in the development of novel and innovative platelet rich plasma products are expected to propel market growth. Market participants are developing advanced products to reinforce their market share and overcome current limitations. In February 2020, Florida-based EmCyte Corporation received FDA’s 510(k) approval for its PurePRP Supraphysiologic Concentrating System, intended for producing platelet rich plasma from a small quantity of blood sample at Point-of-care (PoC) settings. This is an advanced autologous biologic concentrating system that can enable clinicians to improve their work.

The potential value of the market products lies in its ability to include high concentrations of platelet-derived fibrin and growth factors. Several research studies have demonstrated beneficial results with the usage of PRP in a wide range of clinical applications, such as orthopedics, sports medicine, cosmetic surgery, general surgery, neurosurgery, ophthalmic surgery, and others.

PRP injections are widely accepted in the orthopedic treatment, particularly focused towards joint pain relief and other bone defects, propelling the industry growth. It is also used to stimulate the formation of bone in spinal fusion surgeries. Additionally, integration of PRP in the management of COVID-19 patients, as an adjunct therapy is further expected to offer profitable business opportunities for the entities operational in this market.

Request a free sample copy or view report summary: Platelet Rich Plasma Market Report

Platelet Rich Plasma Market Report Highlights

• The pure PRP segment accounted for the largest revenue share of over 52.0% in 2020. Compared to Leukocyte Rich Platelet rich plasma (LR-PRP), pure PRP can promote better repair of bone defects
• LR-PRP can enhance bone regeneration by improving viability, proliferation, migration of cells in vitro, and osteogenesis and angiogenesis in vitro and in vivo
• However, LR-PRP products can produce adverse or inferior effects, making pure type more suitable for bone regeneration
• The combined use of P-PRP with β-tricalcium phosphate (β-TCP) is considered a simple, safe, and effective option in the treatment of bone defects. These factors are expected to boost the utilization of the same
• Orthopedics dominated the market in 2020 accounting for a market share of more than 29.0%, while dermatology is expected to witness the fastest growth rate over the forecast period
• A large number of orthopedic and general surgeries being performed in hospitals is contributing to the dominant share held by hospitals in the market
• The growing competition in the global market can be attributed to the presence of several well-established companies as well as small and midsized entities
• Established manufacturers are observing strategic product developments to ensure maximum product reach
• In October 2019, a new design for packaging was introduced by Croma-Pharma GmbH for the company’s ACP double syringe system. The unique appearance of Croma products has been integrated in this new design. Croma is an exclusive distributor of the Arthrex ACP double syringe system in 9 countries in Europe

Access Press Release of Platelet Rich Plasma Market @ https://www.grandviewresearch.com/press-release/global-platelet-rich-plasma-prp-market

Platelet Rich Plasma Market Segmentation

Grand View Research has segmented the global platelet rich plasma market on the basis of type, application, end-use, and region:

PRP Type Outlook (Revenue, USD Million, 2017 - 2028)

• Pure Platelet Rich Plasma
• Leukocyte Rich Platelet Rich Plasma
• Others

PRP Application Outlook (Revenue, USD Million, 2017 - 2028)

• Orthopedics
• Sports Medicine
• Cosmetic Surgery
• Dermatology
  • Ulcer Healing
    • Venous Ulcer
    • Traumatic Ulcer
    • Diabetic Ulcer
    • Pyoderma Gangrenosum Ulcer
    • Trophic Ulcer
    • Vasculitic Ulcer
    • Others
  • Others
• Ophthalmic Surgery
• Neurosurgery
• General Surgery
• Others

PRP End-use Outlook (Revenue, USD Million, 2017 - 2028)

• Hospitals
• Clinics
• Others

PRP Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
• Asia Pacific
  • China
  • Japan
• Latin America
  • Brazil
  • Mexico
• Middle East and Africa (MEA)
  • South Africa

List of Key Players of Platelet Rich Plasma (PRP) Market

• Johnson & Johnson (DePuy Synthes)
• Zimmer Biomet
• Stryker
• EmCyte Corporation
• Terumo BCT, Inc.;
• Arthrex, Inc.
• PRP America
• Juventix
• APEX Biologix
• Celling BioSciences

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Thermometer Market To Benefit from Increased Global Uptake of 2021 By 2028

 Thermometer Market Growth & Trends

The global thermometer market size is expected to reach USD 2.34 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 8.5% from 2021 to 2028. An increase in the demand for accurate medical devices and the requirement of specific temperature conditions influence the market growth.

The rising cases of medical ailments involving accurate measurement of body temperature for the treatment planning and requirement of specific temperature conditions in various industries are likely to heighten the demand for thermometers during the forecast period. The rise in health consciousness, coupled with an increase in healthcare expenditure, is also anticipated to fuel market growth further in the coming decade.

The increasing prevalence of target diseases, such as malaria, dengue, typhoid, and swine flu, which cause fever, is anticipated to be a high-impact rendering driver of the market. Malaria is one of the most fatal diseases and is one of the leading causes of death globally. According to the World Malaria Report 2019, an estimated 229 million cases of malaria were observed in 2019 globally.

Furthermore, rapid technological advancements in temperature monitoring devices are increasing the acceptance of these devices by people. For instance, in 2018, Optics developed upgrades for its compact infrared thermometers, which improved their speed and flexibility for industrial use. This is expected to boost the market growth during the forecast period.

Request a free sample copy or view report summary: Thermometer Market Report

Thermometer Market Report Highlights

• Based on product, mercury-free thermometers dominated the market with a share of 62.52% in 2020 and are expected to witness significant growth from 2021 to 2028. This can be attributed to the high adoption owing to cost-effectiveness, higher efficacy, and beep indication on temperature fluctuations
• On the basis of application, the medical segment dominated the market with a share of 28.53% in 2020 owing to the high prevalence of diseases, which require body temperature assessment for the treatment planning
• North America dominated the market with a revenue share of 34.45% in 2020 owing to the increasing incidences of infectious diseases, such as COVID-19 and Influenza, and the presence of well-established healthcare facilities in this region

Access Press Release of Thermometer Market @ https://www.grandviewresearch.com/press-release/global-thermometer-market

Thermometer Market Segmentation

Grand View Research has segmented the global thermometer market on the basis of product, application, and region:

Thermometer Product Outlook (Revenue, USD Million, 2016 - 2028)

• Mercury-based Thermometers
• Mercury-free Thermometers
  • Infrared Radiation Thermometers
  • Digital Thermometers
  • Others

Thermometer Application Outlook (Revenue, USD Million, 2016 - 2028)

• Medical
• Industrial
• Food
• Laboratory
• Others

Thermometer Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Mexico
  • Brazil
• Middle East and Africa (MEA)
  • South Africa

List of Key Players of Thermometer Market

• Medline Industries, Inc.
• 3M
• Welch Allyn
• American Diagnostics Corporation
• A&D Medical
• Exergen Corporation
• Microlife Corporation
• RG Medical Diagnostics
• Medtronic
• Terumo Corporation
• Actherm Inc.
• Briggs Healthcare
• OMRON Healthcare Inc.
• Fairhaven Health

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Gene Therapy Market is projected to grow moderately at 20.4% CAGR through 2028: Grand View Research Inc.

 

Gene Therapy Market Growth & Trends

The global gene therapy market size is expected to reach USD 10.0 billion by 2028 registering a CAGR of 20.4% during the forecast period, according to a new report by Grand View Research, Inc. The market growth is attributed to the increasing prevalence of cancer coupled with the lack of effective treatment for the disease. Constant expansion of cancer genetic studies has deciphered relevant information about cancer-related molecular signatures.

This has driven the clinical trials for advanced cancer therapeutics, thereby driving the market growth. In addition, expansion of this mode of treatment in non-cancer applications with approval of therapies, such as approval of Bluebird Bio’s Zynteglo in June 2019 for β-thalassemia and others, demonstrates the shift in the preferences of companies towards other unsaturated segments.

Various universities and institutes are observed to exhibit a broad portfolio in the pipeline, which is anticipated to boost revenue generation in the future. The market is anticipated to witnesses a short-term revenue slowdown due to a shift in focus and delay in product launches. However, initiatives for developing novel trial designs, improving the regulatory environment, and managing the supply chain are expected to play a critical role in minimizing the impact of the current global crisis.

Request a free sample copy or view report summary: Gene Therapy Market Report

Gene Therapy Market Report Highlights

• Viral vectors have proven their efficiency as a method for effective gene deliveries. As a result, a substantial number of research communities and biotechnology companies have designed their gene therapy programs based on viral vectors
• Moreover, most of currently FDA-secured products involve the use of viral vectors, which contributes to the dominance of the viral vectors segment
• Due to the approval and huge success of lentivirus-based Kymriah and retrovirus-based Yescarta, retrovirus and lentivirus are also among the key revenue-generating segments
• Cancer has led the revenue flow in the market over the past few years and is expected to maintain its dominance in the forecast period
• The presence of approved products for various cancer forms including Large B-cell lymphoma, Acute Lymphoblastic Leukemia (ALL), and melanoma has resulted in the dominance of this segment
• The U.S. is recognized as the hub for clinical trials related to gene therapy. This has significantly impacted the revenue growth of the North America market
• Also, the success of Yescarta and Kymriah in the U.S. as the first approved CAR-t therapy programs has driven huge investments by various government agencies, sponsors, and key companies in this region
• Major market participants are partnering with other key stakeholders via signing licensing, commercialization, and development deals to enhance their worldwide business operations
• For instance, in June 2020, uniQure announced a license agreement with CSL Behring for the commercialization of hemophilia B gene therapy

Access Press Release of Gene Therapy Market @ https://www.grandviewresearch.com/press-release/global-gene-therapy-market

Gene Therapy Market Segmentation

Grand View Research has segmented the global gene therapy market on the basis of indication, vector type, and region:

Gene Therapy Indication Outlook (Revenue, USD Million, 2017-2028)

• Acute Lymphoblastic Leukemia (ALL)
• Inherited Retinal Disease
• Large B-cell Lymphoma
• ADA-SCID
• Melanoma (lesions)
• Beta-Thalassemia Major/SCD
• Head & Neck Squamous Cell Carcinoma
• Peripheral Arterial Disease
• Spinal Muscular Atrophy (SMA)
• Others

Gene Therapy Vector Type Outlook (Revenue, USD Million, 2017-2028)

• Lentivirus
• AAV
• Retrovirus & gamma Retrovirus
• Modified Herpes Simplex Virus
• Adenovirus
• Non-viral Plasmid Vector

Gene Therapy Regional Outlook (Revenue, USD Million, 2017-2028)

• North America
  • US.
  • Canada
• Europe
• Asia Pacific
  • Japan
  • China
  • Russia
• Australia
• Rest of the World

List of Key Players of Gene Therapy Market

• REGENXBIO, Inc.
• Oxford BioMedica plc
• Dimension Therapeutics, Inc.
• Bristol-Myers Squibb Company
• SANOFI
• Applied Genetic Technologies Corporation
• Hoffmann-La Roche Ltd.
• Bluebird Bio, Inc.
• Novartis AG
• Taxus Cardium Pharmaceuticals Group, Inc. (Gene Biotherapeutics)
• UniQure N.V.
• Shire Plc
• Cellectis S.A.
• Sangamo Therapeutics, Inc.
• Orchard Therapeutics
• Gilead Lifesciences, Inc.
• Benitec Biopharma Ltd.
• Sibiono GeneTech Co., Ltd.
• Shanghai Sunway Biotech Co., Ltd.
• Gensight Biologics S.A.
• Transgene
• Calimmune, Inc.
• Epeius Biotechnologies Corp.
• Astellas Pharma, Inc.
• American Gene Technologies
• BioMarin Pharmaceuticals, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Wearable Injectors Market Projected to Discern Stable Expansion by 2028

 Wearable Injectors Market Growth & Trends

The global wearable injectors market size is expected to reach USD 18.3 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 17.2% from 2021 to 2028. Wearable injectors are drug administration devices designed to deliver drugs in large volumes subcutaneously. It is gaining popularity owing to its advantages such as reduced pain, ease of administration, and elimination of costly health facility visits.

Over the last decade, patient interest in the self-administration of injectable drug therapies has grown. The increasing prevalence of diabetes, chronic pain, and auto-immune diseases, such as rheumatoid arthritis, is increasing the use of wearable injectors. Their demand is increasing for the long-term management of asthma, chronic obstructive pulmonary disease (COPD), high cholesterol, and cancer. This is expected to create a lucrative opportunity for advanced device manufacturers to make wearable devices used to administer larger dose volumes at the comfort of home.

The recent COVID-19 pandemic has brought remote care technologies, such as wearable injectors, into the spotlight. Demand for chronic disease products remains largely unaffected by the pandemic. Since wearable injectors serve with the option of delivering medications at home, its demand has also remained stable or rather grown for the short term. Patients suffering from chronic diseases are opting for these devices as it reduces the risk of exposure to COVID-19 by eliminating hospital visits. The pandemic has, however, affected some of the devices in the pipeline, affecting short-term investments. Leading players who continue to invest in innovation push projects forward despite COVID-19 are expected to put their companies in a stronger competitive position post-crisis.

Request a free sample copy or view report summary: Wearable Injectors Market Report

Wearable Injectors Market Report Highlights

• By type, the on-body segment led the market in 2020 owing to its advantage to be worn on the skin
• The spring-based technology segment held the largest share of 36.3% in 2020 due to a rise in demand for adhesive patches for the treatment of chronic conditions, such as cancer and diabetes
• The home care end-use segment led the market in 2020. This can be attributed to a rise in preference for self-administration, especially during the COVID-19 pandemic
• North America dominated the market with a share of 41.5% in 2020 owing to the rising prevalence of chronic diseases

Access Press Release of Wearable Injectors Market @ https://www.grandviewresearch.com/press-release/global-wearable-injectors-market

Wearable Injectors Market Segmentation

Grand View Research has segmented the global wearable injectors market based on type, technology, application, end-use, and region:

Wearable Injectors Type Outlook (Revenue, USD Million, 2016 - 2028)

• On-body
• Off-body

Wearable Injectors Technology Outlook (Revenue, USD Million, 2016 - 2028)

• Spring-based
• Motor-driven
• Rotary Pump
• Expanding Battery
• Others

Wearable Injectors Application Outlook (Revenue, USD Million, 2016 - 2028)

• Oncology
• Infectious Diseases
• Cardiovascular Diseases
• Autoimmune Diseases
• Others

Wearable Injectors End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospitals
• Clinics
• Home Care
• Others

Wearable Injectors Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
• Asia Pacific
  • Japan
  • China
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa

List of Key Players of Wearable Injectors Market

• Becton, Dickinson and Company
• Johnson & Johnson Services, Inc.
• Hoffmann-La Roche Ltd.
• Unilife Corporation
• SteadyMed Therapeutics, Inc.
• Amgen, Inc.
• Insulet Corporation
• Enable Injections
• West Pharmaceutical Services, Inc.
• CeQur SA

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.